₨ 140.00
MBBS
REPASCOT 2mg Tablet 1x10s
- Does this requires a prescription ? Yes
- Generic Name: Repaglinide:2mg
- Manufactured by : Scotmann Pharmaceuticals
- Drug Strength : 2mg
- Drug Form : Tablet
- Pack Size : 1x10s
- Product SKU : dis_32417
Repaglinide:2mg | Oral hypoglycemics
Alternate brands of REPASCOT 2mg Tablet 1x10s
| Brand Name | Price | Savings |
|---|---|---|
| REPAG 2mg Tablet 10s | ₨ 300.00 | You will pay -160 more |
| RAPTROL 2mg Tablet 3x10s | ₨ 420.00 | You will pay -280 more |
| RAPAGLAX 2mg Tablet 3x10s | ₨ 420.00 | You will pay -280 more |
| LIMZEL 2mg Tablet 3x10s | ₨ 420.00 | You will pay -280 more |
Manufactured / Marketed By : ScotmannProduct Form : TabletPack Size : 1x10sIngredients : Repaglinide:2mgGeneric Category : Oral hypoglycemics
How it works
REPASCOT 2mg Tablet 1x10s works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. How to use Repaglinide
Concerns
Frequently asked questions
-
Onset of action
-
Duration of Effect
-
Safe with Alchohol?
-
Is it habit forming?
-
Usage in pregnancy?
-
Usage while breast-feeding?
Dosage
-
Missed Dose
-
Overdose
References
- webmd.com - Repaglinide [Internet]. Available from: https://www.webmd.com/drugs/2/drug-6614/repaglinide-oral/details [cited 27/7/2020].
One of the following licensed pharmacy from the nearest location will deliver REPASCOT 2mg Tablet 1x10s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
-
-7%
-
-14%
Out of stock
-
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.